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Compound 16 
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Tubulin polymerization assay 
Effect of compound 6 on tubulin polymerization was determined using method of Gaskin, Cantor 
and Shelanski,i with some modifications. Tubulin was isolated from bovine brain as described previously.ii 
Freshly prepared tubulin solution at approximate concentration of 2.2 mg/ml and MES (2-(N-
morpholino)ethanesulfonic acid) buffer containing GTP were kept on ice before the experiment. Stock 
solutions of paclitaxel and compound 6 were prepared in DMSO at concentration of 10-2 M, and 
afterwards diluted with DMSO/H20 (1:1 v/v) to 10-3 M. From this solution, the desired concentrations (in 
range of 1-1000 µM) were prepared in H2O. Solutions of various concentrations of paclitaxel (positive 
control) and examined compound 6 (40 µL) were added to a tubulin solution (360 μL) and incubated for 
45 minutes at 37 ºC. Mixture of 40 µL MES buffer and 360 of μL tubulin solution was used as blank. 
After incubation, solutions were transferred to UV cuvettes and absorbance was measured at 350 nm 
continuously for 15 minutes on an instrument cooled to 4 ºC. Percentage of tubulin polymerization was 
determined as difference in absorbance at t=0 min (37 ºC) and t=15 min (4 ºC), comparing to 
corresponding difference for a blank. Effect of paclitaxel and investigated compound 6 on polymerization 
of purified tubulin was expressed as IC50, i.e. concentration of agents producing 50% tubulin 
polymerization. UV absorption was measured on a GBC Cintra 40 UV-Visible spectrometer equipped 
with thermostatic circulator Petrotest 25-0395. 
 Different concentrations of compound 6 (0.1, 1, 5, 10, and 50 µM) were incubated with tubulin 
solution and microtubule disassembly was followed turbidimetrically. The results are presented in Figure 
1. The IC50 value, determined by graphical method, was ~ 9 µM. Paclitaxel, which was used as positive 
control, showed IC50 value of ~ 0.7 µM (Figure 2). 
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Figure 1. The effect of compound 6 on tubulin polymerization 
conc. (μM) % of polimerization 
0.1 14.73 
1 24.19 
5 41.99 
10 52.32 
50 97.16 
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Paclitaxel 
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Figure 2. The effect of paclitaxel on tubulin polymerization 
conc. (μM) % of polimerization 
0.1 9.5 
0.5 44.25 
1 56.07 
5 79.97 
10 89.99 
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Cytotoxicity of paclitaxel and compound 6 in L929 mouse fibrosarcoma cells 
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Figure 3. Cytotoxicity of paclitaxel and compound 6 in L929 mouse fibrosarcoma cells. (A) L929 cells 
were incubated with different concentrations of paclitaxel or compound 6 for 24 h and cell viability was 
assessed by crystal violet staining. Data are mean ± SD of triplicate measurements (*p < 0.05). (B-D) 
L929 cells were treated with paclitaxel (0.5 µM) or compound 6 (4 µM). Cell cycle distribution (B) and 
caspase activation (C) were determined by flow cytometry after 24 h, while immunoblot analysis of LC3 
conversion, p62 and phospho-S6K (pS6K) levels was performed after 16 h of incubation (D).   
                                                            
iGaskin, F.; Cantor, C. R.; Shelanski, M. L. Turbidimetric studies of the in vitro assembly and disassembly of porcine 
neurotubules. J. Mol. Biol 1974, 89, 737–755. 
iiShelanski, M. L.; Gaskin, F.; Cantor, C. R. Microtubule Assembly in the Absence of Added Nucleotides. Proc. 
Natl. Acad. Sci. U.S.A. 1973, 70, 765–768. 
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